Home > Publications >YAP/TAZ Inhibition Induces Metabolic and Signaling Rewiring Resulting in Targetable Vulnerabilities in NF2-Deficient Tumor Cells >

<<Previous Next>>

Post Date:Jul-21-20

YAP/TAZ Inhibition Induces Metabolic and Signaling Rewiring Resulting in Targetable Vulnerabilities in NF2-Deficient Tumor Cells

AcceGenAuthor: AcceGen R&D Team

Date Published: 21-Jul-20

YAP/TAZ Inhibition Induces Metabolic and Signaling Rewiring Resulting in Targetable Vulnerabilities in NF2-Deficient Tumor Cells

  • Authors: Shannon M. White, Maria Laura Avantaggiati, Ivan Nemazanyy, Cristina Di Poto, Yang Yang, Mario Pende, Geoffrey T. Gibney, Habtom W. Ressom, Jeffery Field, Michael B. Atkins, Chunling Yi
  • Journal: DEVELOPMENTAL CELL
  • DOI: 10.1016/j.devcel.2019.04.014
  • Cited AcceGen Product/Service:

<<Previous Next>>

AcceGen Scroll Top Button
Copy link